rhPLD2 suppresses chronic inflammation reactions in a guinea pig asthma model^*

References

• Lloyd, C.M., Hessel, E.M. Functions of T cells in asthma: More than just T(H)2 cells. Nat. Rev. Immunol. 2010, 10, 838–848.
   PubMed Web of Science ®Google Scholar
• Chaudhary, D., Kasaian, M. PKCtheta: A potential therapeutic target for T-cell-mediated diseases. Curr. Opin. Investig. Drugs 2006, 7, 432–437.
   PubMedGoogle Scholar
• Langlois, A., Chouinard, F., Flamand, N., Ferland, C., Rola-Pleszczynski, M., Laviolette, M. Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J. Leukoc. Biol. 2009, 85, 656–663.
   PubMed Web of Science ®Google Scholar
• Egwuagu, C.E. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 2009, 47, 149–156.
   PubMed Web of Science ®Google Scholar
• Hiroaki, T., Hiroshi, N., Koichi, H., Shin-ichiro, K., Tomohiro, T., Akira, S., Kotaro, S., Yasushi, S., Itsuo, I. Indispensable Role of STAT5a in Stat6-Independent Th2 Cell Differentiation and Allergic Airway Inflammation. The Journal of Immunology 2005, 174, 3734–3740.
   PubMed Web of Science ®Google Scholar
• Roth, M.G. Molecular mechanisms of PLD function in membrane traffic. Traffic 2008, 9, 1233–1239.
   PubMed Web of Science ®Google Scholar
• Gomez-Cambronero, J. New concepts in phospholipase D signaling in inflammation and cancer. ScientificWorldJournal. 2010, 10, 1356–1369.
   Google Scholar
• Mansfeld, J., Ulbrich-Hofmann, R. Modulation of phospholipase D activity in vitro. Biochim. Biophys. Acta 2009, 1791, 913–926.
   PubMed Web of Science ®Google Scholar
• Ogino, C., Daido, H., Ohmura, Y., Takada, N., Itou, Y., Kondo, A., Fukuda, H., Shimizu, N. Remarkable enhancement in PLD activity from Streptoverticillium cinnamoneum by substituting serine residue into the GG/GS motif. Biochim. Biophys. Acta 2007, 1774, 671–678.
   PubMed Web of Science ®Google Scholar
• Liu, Q., Zhang, C., Yang, Y., Hu, X. Genome-wide and molecular evolution analyses of the phospholipase D gene family in Poplar and Grape. BMC Plant Biol. 2010, 10, 117.
   PubMed Web of Science ®Google Scholar
• Ling, Z., Jian-Feng, X., Chuan-Xing, Y., Hui-Min, L., Wei-Da, H. Expression of mutation form proteins of human recombinant Phospholipase D2 in E. coli and its bioactivities. Chinese Journal of Zoonoses 2008, 24, 991–998.
   Google Scholar
• Ling, Z., Jian-Feng X., Chuan-Xing Y., Don-Hui S., Wei-Da, H., Ru. Huang Analysis of cDNA and protein sequence of rhPLD2 mutation form. Journal of Chinese Biotechnology 2003, 23, 80–84.
   Google Scholar
• Ling, Z., Wei-Bin, Z., Chuan-Xing, Y., Jun-Jin, L., Xiao-Li, H. Human recombinant PLD2 (rhPLD2) in vivo can significantly repress the p65 activity in chronic asthma of guinea pigs. Cellular & Molecular Immunology, 2006, 3, 307–310.
   PubMed Web of Science ®Google Scholar
• Ling, Z., Xue-Peng, X., Jun-Jin, L., Xiao-Li, H. Reductive effect of rhPLD2 on PAF content in serum of guinea pig model with chronic asthma. Chinese Journal of Immunology 2006, 22, 360–363.
   Google Scholar
• Jong Hyun, K., Jung Hwan, K., Motoi, O., Pann-Ghill, S., Sung Ho, R. Novel functions of the phospholipase D2-phox homology domain in protein kinase C activation. Molecular and Cellular Biology 2005, 25, 3194–3208.
   PubMed Web of Science ®Google Scholar
• Kuo, T.C., Huang, W.J., Guh, J.H. WJ9708012 exerts anticancer activity through PKC-a related crosstalk of mitochondrial and endoplasmic reticulum stresses in human hormone-refractory prostate cancer cells. Acta Pharmacol. Sin. 2011, 32, 89–98.
   PubMed Web of Science ®Google Scholar
• De-shou, D., Lin-lin, Z., Xiao-xiang, L., Xiu-bin, F. The inhibitory effect of dexamethasone on the expression of PKC in the lung, the spinal ganglia and the spinal dorsal horns of the asthmatic guinea pigs. Acta Anatomica Sinica 2006, 37, 17–20.
   Google Scholar
• Hyung-Kyoung, L., Seungeun, Y., Jin-Sik, K., Jin-Gu, L., Yoe-Sik, B., Chuhee, L., Suk-Hwan, B. Protein kinase C-η and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2. Molecular Pharmacology, 2010, 78, 478–485.
   PubMed Web of Science ®Google Scholar
• Imen, N., Baran-Marszak, F., Christopher Le, C., Christelle, L., Olivier, S., Youlyouz-Marfak, I., Martin, S., Georg, W.B., Martine, R., Jean, F., Remi, F. Latent membrane protein 1 regulates STAT1 through NF-κB dependent interferon secretion in Epstein-Barr virus-immortalized B cells. Journal of virology 2005, 79, 4936–4943.
   PubMed Web of Science ®Google Scholar
• Wenjuan, S., Qin, C., Michael, A.F. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol 2009, 5, 1477–1483.
   PubMed Web of Science ®Google Scholar
• Ling, Z., Wei-Bin, Z., Chuan-Xing, Y., Xiao-Li, H., Jun-Jin, L. Human recombinant PLD2 (rhPLD2) and DXM in vivo may significantly inhibit the high level expression of GPI-PLD in chronic asthma of guinea pigs. Chinese Journal of Biochemistry & Molecular Biology 2007, 23, 116–121.
   Google Scholar
• Singh, R.K., Jia, C., Garcia, F., Carrasco, G.A., Battaglia, G., Muma, N.A. Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone release. J. Psychopharmacol. (Oxford) 2010, 24, 1079–1088.
   PubMed Web of Science ®Google Scholar